Case Grows For Bayer's Old Anti-Malarial To Treat COVID-19
German Major Advises Caution Over Chloroquine
Bayer's anti-malaria therapy chloroquine is being touted as a cheap, safe and effective drug for coronavirus. However the company's product is only made in Pakistan and a variety of import and export agreements need to be in place for other countries to get hold of it.
You may also be interested in...
Although Gilead’s remdesivir shows promise against the coronavirus, efficacy is not guaranteed, one antiviral company executive tells Scrip, as multiple other potential therapies and vaccines move forward.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
The diagnostics tie-up with GSK on testing is a near-term move to help the UK get back to normality, the drug major's biopharmaceuticals R&D boss tells Scrip. AstraZeneca's main focus is to develop monoclonal antibodies to tackle 'wave two' of the coronavirus.